These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 7295092

  • 1. Characterization of middle molecule compounds.
    Zimmerman L, Jörnvall H, Bergström J, Fürst P, Sjövall J.
    Artif Organs; 1981; 4 Suppl():33-6. PubMed ID: 7295092
    [Abstract] [Full Text] [Related]

  • 2. Characterization of sub-peak b4.2, middle molecule.
    Cueille G, Man NK, Sausse A, Farges JP, Funck-Brentano JL.
    Artif Organs; 1981; 4 Suppl():28-32. PubMed ID: 7295091
    [Abstract] [Full Text] [Related]

  • 3. Plasma middle molecules in asymptomatic and "sick" uremic patients.
    Asaba H, Bergström J, Fürst P, Johnson C, Yahiel V.
    Artif Organs; 1981; 4 Suppl():137-42. PubMed ID: 7295080
    [Abstract] [Full Text] [Related]

  • 4. Uremic middle molecules in non-dialyzed azotemic patients: relation to symptoms and clinical biochemistries.
    Asaba H, Alvestrand A, Bergström J, Fürst P, Yahiel V.
    Clin Nephrol; 1982 Feb; 17(2):90-5. PubMed ID: 7067171
    [Abstract] [Full Text] [Related]

  • 5. Isotachophoretic separation of middle molecule peptides in uremic body fluids.
    Zimmerman L, Baldesten A, Bergström J, Fürst P.
    Clin Nephrol; 1980 Apr; 13(4):183-8. PubMed ID: 7379369
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Middle molecules in uremic serum, urine and dialysis fluid.
    Migone L, Dall'taglio P, Buzio C.
    Clin Nephrol; 1975 Apr; 3(3):82-93. PubMed ID: 1139803
    [Abstract] [Full Text] [Related]

  • 8. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G, Chu J, Liu X, Yuan Z.
    Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
    [Abstract] [Full Text] [Related]

  • 9. Determination of endogenous middle molecules in normal and uremic body fluids.
    Fürst P, Zimmerman L, Bergström J.
    Clin Nephrol; 1976 Apr; 3(2):178-88. PubMed ID: 1277595
    [Abstract] [Full Text] [Related]

  • 10. Technical aspects on middle molecules: separation, isolation, and identification.
    Cueille G, Man NK, Sausse A, Farges JP, Funck-Brentano JL.
    Artif Organs; 1981 Apr; 4 Suppl():8-12. PubMed ID: 7295100
    [Abstract] [Full Text] [Related]

  • 11. Uremic middle molecules: analytical study of middle molecular weight fractions subpeak b4-2.
    Le Moel G, Strecker G, Cueille G, Boudet J, Man NK, Galli A, Agneray J.
    Artif Organs; 1981 Apr; 4 Suppl():17-21. PubMed ID: 7295087
    [Abstract] [Full Text] [Related]

  • 12. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R, Emond C, Claret G, Branger B, Mion H, Mion C.
    Artif Organs; 1981 Apr; 4 Suppl():177-83. PubMed ID: 7295089
    [Abstract] [Full Text] [Related]

  • 13. What remains of the "middle molecule" hypothesis today?
    Brunner H, Mann H.
    Contrib Nephrol; 1985 Apr; 44():14-39. PubMed ID: 3886282
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
    Ringoir SM, van Landschoot N, de Smet R.
    Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Parathyroid hormone immunoreactivity in the plasma filtrate of uremic patients.
    Tsutsumi M, Fukase M, Fujita T, Fujita K, Inoue S, Shin J.
    Miner Electrolyte Metab; 1982 Mar; 7(3):146-50. PubMed ID: 7169980
    [Abstract] [Full Text] [Related]

  • 17. A compound from uremic plasma and from normal urine isolated by liquid chromatography and identified by nuclear magnetic resonance.
    Gallice P, Monti JP, Crevat A, Durand C, Murisasco A.
    Clin Chem; 1985 Jan; 31(1):30-4. PubMed ID: 3965216
    [Abstract] [Full Text] [Related]

  • 18. A new glycine containing compound with a blocked amino group from uremic body fluids.
    Zimmerman L, Fürst P, Bergström J, Jörnvall H.
    Clin Nephrol; 1980 Sep; 14(3):107-11. PubMed ID: 7418276
    [Abstract] [Full Text] [Related]

  • 19. Clinical implications of uremic middle molecules in regular hemodialysis patients.
    Asaba H, Alvestrand A, Fürst P, Bergström J.
    Clin Nephrol; 1983 Apr; 19(4):179-87. PubMed ID: 6851254
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.